Journal
GENES CHROMOSOMES & CANCER
Volume 60, Issue 1, Pages 17-25Publisher
WILEY
DOI: 10.1002/gcc.22898
Keywords
epithelioid hemangioma; FOS; FOSB; fusions
Categories
Funding
- EHE Foundation
- Kristin Ann Carr Foundation
- Memorial Sloan-Kettering Cancer Center
- National Institutes of Health [P30 CA008748, P50 CA 140146, P50 CA 217694]
Ask authors/readers for more resources
Diagnosing and classifying epithelioid hemangioma can be challenging, but molecular testing can help define its clinical and pathologic characteristics. This skeletal condition is characterized by local aggressiveness and a high rate of local recurrence, but has a low likelihood of metastasis.
The diagnosis of epithelioid hemangioma (EH) remains challenging due to its rarity, worrisome histologic features, and locally aggressive clinical and radiographic presentation. Especially in the bone, EH can be misdiagnosed as a malignant vascular neoplasm due its lytic, often destructive or multifocal growth, as well as atypical morphology. The discovery of recurrentFOSandFOSBgene fusions in the pathogenesis of most EH has strengthened its stand-alone classification, distinct from other malignant epithelioid vascular lesions, such as epithelioid hemangioendothelioma or angiosarcoma. In this study we investigate a group of molecularly confirmed skeletal EH by the presence ofFOSorFOSBgene rearrangements to better define its clinical and pathologic characteristics within a homogenous molecular subset. The cohort included 38 patients (25 males, 13 females), with a mean age at diagnosis of 38 years (range, 4-75). Regional, multifocal presentation was noted in 10 cases. Only six cases were correctly recognized as EH by the referring institutions, while most were misdiagnosed as other vascular tumors. Of the 17 patients with follow-up data available, five patients (29%) developed local recurrence after marginal en bloc excision (n = 3) or curettage (n = 2). Local recurrence-free survival rates were 84% at 3 years and 38% at 5 years. No metastasis or disease-related death was identified. Imaging studies exhibited no specific features, showing cortical bone destruction and soft-tissue extension in 14 (38%) cases.FOSgene rearrangements were detected in 28 (74%) of cases, whileFOSBrearrangements in 10 (26%) cases. Our results highlight the significant challenges encountered in establishing a correct diagnosis exclusive of the molecular testing, mainly due to its overlap to other malignant epithelioid vascular tumors. Skeletal EH emerges as a genetically defined locally aggressive vascular neoplasm, with a high rate of local recurrence, but lacking the propensity for distant spread.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available